Reuters US Business

Australia to allow workers to ignore after-hours calls from bosses

By Praveen Menon SYDNEY (Reuters) – Australia will introduce laws giving workers the right to ignore unreasonable calls and messages from their bosses outside of work hours without penalty, with potential fines for employers that breach the rule. The “right to disconnect” is part of a raft of changes to industrial relations laws proposed by …

Australia to allow workers to ignore after-hours calls from bosses Read More »

Boeing 737 MAX 9 door plug bolts appeared to be missing on Alaska jet, NTSB says

By David Shepardson WASHINGTON (Reuters) -A door panel that flew off a Boeing 737 MAX 9 jet mid-flight on Jan. 5 appeared to be missing four key bolts, according to a preliminary report from U.S. investigators that provided the first official look into how the frightening mishap took shape. Lawmakers and the flying public have …

Boeing 737 MAX 9 door plug bolts appeared to be missing on Alaska jet, NTSB says Read More »

Chipotle beats quarterly sales estimates on strong demand

(Reuters) -Chipotle Mexican Grill topped market estimates for quarterly sales on Tuesday, as Americans ordered more of its burritos and rice bowls despite menu items getting pricier, underscoring its resilience in a choppy macro environment. Shares of the California-based company were up about 2% in extended trading. While the U.S. restaurant industry has seen customer …

Chipotle beats quarterly sales estimates on strong demand Read More »

Gilead quarterly revenue drops 4%, oral COVID drug fails trial

By Deena Beasley (Reuters) – Gilead Sciences on Tuesday said its fourth-quarter revenue dipped 4% on lower sales of HIV drugs and Veklury, an infused drug for hospitalized COVID-19 patients, while its adjusted profit rose 3% due to lower expenses. Gilead also said a large trial of its experimental oral COVID antiviral drug, obeldesivir, did …

Gilead quarterly revenue drops 4%, oral COVID drug fails trial Read More »

Amgen quarterly profit rises 15% as Horizon deal boosts results

By Deena Beasley (Reuters) – Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company’s October acquisition of rare disease drugmaker Horizon Therapeutics. Revenue for the quarter totaled $8.2 billion, edging ahead of analysts’ estimates of $8.1 billion, according to LSEG data. Excluding Horizon’s …

Amgen quarterly profit rises 15% as Horizon deal boosts results Read More »

S&P 500 closes up; focus on earnings and US interest rates

By Sinéad Carew and Johann M Cherian (Reuters) -The S&P 500 closed slightly higher on Tuesday, as investors scrutinized a mixed bag of earnings at big U.S. companies and digested comments from Federal Reserve policy makers for clues about its first planned interest-rate cut. Minneapolis Fed President Neel Kashkari said the central bank is “not …

S&P 500 closes up; focus on earnings and US interest rates Read More »

Volkswagen to invest around 180 billion eur through 2028 – Handelsblatt

BERLIN (Reuters) – Volkswagen plans to keep investments in the coming five years stable at around 180 billion euros ($193.59 billion) between 2024 and 2028, Germany’s Handelsblatt newspaper reported on Tuesday, citing three people familiar with the matter. The supervisory board had approved the investment plan but added a condition that the sum could be …

Volkswagen to invest around 180 billion eur through 2028 – Handelsblatt Read More »

Close Bitnami banner
Bitnami